Group 1: Company Overview - Guangzhou Maipu Regenerative Medicine Technology Co., Ltd. is focused on neurosurgery, providing comprehensive solutions for neurosurgical repairs [2][3]. - The company is the only domestic enterprise with a range of implantable medical devices, including artificial dura mater patches and absorbable regenerated cellulose [3][4]. Group 2: Future Strategies - The company aims to enhance its marketing system and expand its market share in the neurosurgery field, targeting a broader product portfolio [3][4]. - Plans include extending technology applications to other surgical fields, such as hemostatic products and dental restoration [3][4]. Group 3: Market Presence - The dura mater medical glue has been sold in over 20 countries and regions, including Europe and Asia, with corresponding registrations obtained [4]. - The company is committed to maintaining its competitive advantage in the neurosurgery sector while exploring new product lines to meet clinical needs [3][4]. Group 4: Investor Engagement - The company held an investor relations activity on September 12, 2024, to address investor inquiries regarding future sales strategies and market share [2][3]. - Investors were encouraged to reach out for further inquiries or suggestions through the investor hotline [4].
迈普医学(301033) - 2024年9月12日投资者关系活动记录表